Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Go back to Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
(NASDAQ: MDCX) Delayed: 0.45 -0.01 (2.17%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.40    EPS
Volume 2,875,785       

(NASDAQ: MDCX) Delayed: 0.45 -0.01 (2.17%)
Previous Close $0.46    52 Week High
Open $0.46    52 Week Low
Day High $0.46    P/E N/A 
Day Low $0.40    EPS
Volume 2,875,785